Viewing nowCombinationDapaem Sustained Release Tablet 10/1000 mg
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Biosciences, Co., Ltd.

MFDS item code 202106874 · Approved 2021.10.12 · Insurance code 645210650
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is particularly recommended for patients who are not sufficiently controlled with current treatment and have cardiovascular disease or risk factors, hence consulting a specialist regarding the cardiovascular impact of dapagliflozin is advised. This medication is used to improve glycemic control in type 2 diabetes patients.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and metformin extended-release 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/metformin extended-release 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. In patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the patient's current metformin dose or an appropriate therapeutically equivalent dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjustments made as appropriate. In patients switching from combination therapy with dapagliflozin and metformin to this medicine, the dose of this medicine may be started at the doses of dapagliflozin and metformin previously being taken. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and dosage adjustments made as appropriate. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because such a change may cause changes in glycemic control, any change in treatment in patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dosage adjustment is necessary in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who do not have other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted through the kidneys and renal function is more likely to be decreased in elderly patients, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).
This medication is used in the treatment of diabetes and helps regulate blood sugar levels. It can rarely result in a serious metabolic complication known as lactic acidosis, and should not be used if kidney function is poor or in cases of severe infection or dehydration. Care should be taken when using alongside other diabetes medications due to the risk of hypoglycemia, particularly with insulin or sulfonylureas, whereby dosage adjustment may be required. It should not be administered to patients with moderate to severe renal dysfunction, severe liver dysfunction, acute heart disease or severe infection, women who are pregnant or breastfeeding, and patients undergoing dialysis. Administration should be temporarily suspended before and after surgery or imaging tests involving iodine contrast agents, and caution is necessary in patients with reduced fluid volume or risk of hypotension. Regular monitoring of kidney function and fluid status is essential during treatment, and any unusual symptoms should prompt immediate consultation with healthcare professionals. This medication can cause side effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, headache, dizziness, dyspepsia, and other ailments, warranting caution. Elderly patients or those with compromised renal function are at a higher risk of side effects, thus requiring dosage adjustments and regular check-ups. During pregnancy or breastfeeding, this medication should not be used, and if pregnancy is confirmed, it should be discontinued immediately. In cases of overdose, immediate treatment is necessary, and some components may be removed via dialysis. While this medication does not significantly affect driving or operating machinery, caution is warranted in case of dizziness or similar symptoms. Keep this medication out of the reach of children and store in its original container to prevent quality deterioration or misuse.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air or moisture. It is best to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Storing it this way will help maintain its efficacy for a longer period.
Yellow, oval, biconvex film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aprogen Biosciences, Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationDapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Poonglim Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Punglim Muhak Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
KS Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.